Table 3.
The percentage prevalence of SAV nsP1 in sera and hearts as an average of 3 or 2 tanks per group and 95% confidence intervals (CI)
Dose dpe | Sera | Hearts | ||||||
---|---|---|---|---|---|---|---|---|
7 | 10 | 14 | 21 | 7 | 10 | 14 | 21 | |
Low | ||||||||
Mean | 0 | 4.2 | 27.8 | 16.7 | 4.2 | 0 | 4.2 | 6.7 |
95% CI | 0–14.3 | 0.1–21.1 | 9.7–53.5 | 4.7–37.4 | 0.1–21.1 | 0–14.3 | 0.1–21.1 | 0.1–23.8 |
Medium | ||||||||
Mean | 16.7 | 20.8 | 66.7 | 87.5 | 0 | 25.0 | 54.2 | 95.8 |
95% CI | 4.7–37.4 | 7.1–42.2 | 44.7–84.4 | 67.6–97.3 | 0–14.3 | 9.8–46.7 | 32.8–74.5 | 76.2–100 |
High | ||||||||
Mean | 62.5 | 81.2 | 100 | 81.2 | 50.0 | 62.5 | 93.8 | 100 |
95% CI | 35.4–84.8 | 54.6–96.0 | 79.4–100 | 54.4–96.0 | 24.7–75.4 | 35.4–84.8 | 69.8–99.8 | 79.4–100 |
dpe: days post-exposure.